Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.

Barclay M, Gildea C, Poole J, Hirschowitz L, Menon U, Nordin A.

Int J Gynecol Cancer. 2016 Jan;26(1):56-65. doi: 10.1097/IGC.0000000000000562.

PMID:
26509852
2.

Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.

Rosendahl M, Høgdall CK, Mosgaard BJ.

Int J Gynecol Cancer. 2016 May;26(4):680-7. doi: 10.1097/IGC.0000000000000675.

PMID:
26937751
3.

Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).

Dahm-Kähler P, Borgfeldt C, Holmberg E, Staf C, Falconer H, Bjurberg M, Kjölhede P, Rosenberg P, Stålberg K, Högberg T, Åvall-Lundqvist E.

Gynecol Oncol. 2017 Jan;144(1):167-173. doi: 10.1016/j.ygyno.2016.10.039. Epub 2016 Nov 3.

PMID:
27817932
4.

Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals.

Paulsen T, Kjaerheim K, Kaern J, Tretli S, Tropé C.

Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:11-7.

PMID:
16515561
5.

Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.

Usach I, Blansit K, Chen LM, Ueda S, Brooks R, Kapp DS, Chan JK.

Am J Obstet Gynecol. 2015 Feb;212(2):188.e1-6. doi: 10.1016/j.ajog.2014.08.016. Epub 2014 Aug 18.

PMID:
25149685
6.

Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology--a prospective comparative study.

Schnack TH, Sørensen RD, Nedergaard L, Høgdall C.

Gynecol Oncol. 2014 Nov;135(2):278-84. doi: 10.1016/j.ygyno.2014.08.020. Epub 2014 Aug 26.

PMID:
25168689
7.

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.

Finch AP, Lubinski J, Møller P, Singer CF, Karlan B, Senter L, Rosen B, Maehle L, Ghadirian P, Cybulski C, Huzarski T, Eisen A, Foulkes WD, Kim-Sing C, Ainsworth P, Tung N, Lynch HT, Neuhausen S, Metcalfe KA, Thompson I, Murphy J, Sun P, Narod SA.

J Clin Oncol. 2014 May 20;32(15):1547-53. doi: 10.1200/JCO.2013.53.2820. Epub 2014 Feb 24.

8.

Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer.

Einenkel J, Ott R, Handzel R, Braumann UD, Horn LC.

Int J Gynecol Cancer. 2009 Oct;19(7):1288-97. doi: 10.1111/IGC.0b013e3181a3a833.

PMID:
19823067
9.

Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience.

Safra T, Berman T, Yachnin A, Bruchim I, Meirovitz M, Barak F, Atlas I, Levy T, Rosengarten OS.

Int J Gynecol Cancer. 2013 Mar;23(3):475-80. doi: 10.1097/IGC.0b013e3182866944.

PMID:
23435437
10.

Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?

Reitsma W, de Bock GH, Oosterwijk JC, ten Hoor KA, Hollema H, Mourits MJ.

Int J Gynecol Cancer. 2012 May;22(4):579-85. doi: 10.1097/IGC.0b013e31823d1b5c.

PMID:
22274543
11.

Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004.

Goodman MT, Shvetsov YB.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):132-9. doi: 10.1158/1055-9965.EPI-08-0771.

12.

Cancer of the ovary, fallopian tube, and peritoneum.

Berek JS, Crum C, Friedlander M.

Int J Gynaecol Obstet. 2015 Oct;131 Suppl 2:S111-22. doi: 10.1016/j.ijgo.2015.06.007. No abstract available.

13.

Prognostic role of early versus late onset of bone metastasis in patients with carcinoma of the ovary, peritoneum and fallopian tube.

Sehouli J, Olschewski J, Schotters V, Fotopoulou C, Pietzner K.

Ann Oncol. 2013 Dec;24(12):3024-8. doi: 10.1093/annonc/mdt398. Epub 2013 Oct 14.

PMID:
24130264
14.

Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.

Luyckx M, Leblanc E, Filleron T, Morice P, Darai E, Classe JM, Ferron G, Stoeckle E, Pomel C, Vinet B, Chereau E, Bergzoll C, Querleu D.

Int J Gynecol Cancer. 2012 Oct;22(8):1337-43.

PMID:
22964527
15.

Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary.

Massad LS, Gao F, Hagemann I, Powell M.

Gynecol Obstet Invest. 2016;81(5):411-5. doi: 10.1159/000441791. Epub 2015 Nov 20.

16.

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.

Wahner Hendrickson AE, Hawthorne KM, Goode EL, Kalli KR, Goergen KM, Bakkum-Gamez JN, Cliby WA, Keeney GL, Visscher DW, Tarabishy Y, Oberg AL, Hartmann LC, Maurer MJ.

Gynecol Oncol. 2015 Apr;137(1):77-85. doi: 10.1016/j.ygyno.2015.01.539. Epub 2015 Jan 22.

17.

International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.

Pereira A, Pérez-Medina T, Magrina JF, Magtibay PM, Rodríguez-Tapia A, Peregrin I, Mendizabal E, Ortiz-Quintana L.

Int J Gynecol Cancer. 2015 Jan;25(1):49-54. doi: 10.1097/IGC.0000000000000316.

PMID:
25405578
18.

Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US.

Liao CI, Chow S, Chen LM, Kapp DS, Mann A, Chan JK.

Gynecol Oncol. 2018 May;149(2):318-323. doi: 10.1016/j.ygyno.2018.01.030. Epub 2018 Mar 4.

PMID:
29514737
19.

The significance of the pattern of serum CA125 level ascent to above the normal range in epithelial ovarian, primary peritoneal and tubal carcinoma patients.

Levy T, Weiser R, Boaz M, Ben Shem E, Golan A, Menczer J.

Gynecol Oncol. 2013 Apr;129(1):165-8. doi: 10.1016/j.ygyno.2012.12.024. Epub 2012 Dec 27.

PMID:
23274778
20.

Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities - a systematic review.

Sørensen RD, Schnack TH, Karlsen MA, Høgdall CK.

Gynecol Oncol. 2015 Mar;136(3):571-81. doi: 10.1016/j.ygyno.2015.01.534. Epub 2015 Jan 20. Review.

PMID:
25615934

Supplemental Content

Support Center